IRINOTECAN HYDROCHLORIDE

irinotecan hydrochloride · Actavis Pharma, Inc.

Drug timelines are a Plus or Pro feature.

51 regulatory and trial events tracked for IRINOTECAN HYDROCHLORIDE, covering 2008-02-27 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery [Phase 1]

See pricing